Neural Mobilization on Multiple Sclerosis

Sponsor
Kahramanmaras Sutcu Imam University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06153264
Collaborator
(none)
40
1
2
10
4

Study Details

Study Description

Brief Summary

Current treatments for pain in MS patients include the use of non-pharmacological interventions such as electrotherapy and exercise, as well as pharmacological treatments. Neurodynamic mobilization exercises are an intervention that aims to restore homeostasis in and around the nervous system by activating the nervous system itself or the structures surrounding the nervous system. Neurodynamic mobilization facilitates movement between neural structures and their environment through manual techniques and exercise. Human and animal studies reveal that neurodynamic mobilization reduces intraneural edema, improves intraneural fluid distribution, reduces thermal and mechanical hyperalgesia, and reverses increased immune responses following a nerve injury.

Condition or Disease Intervention/Treatment Phase
  • Other: neurodynamic mobilization exercise
  • Other: strengthening exercises
N/A

Detailed Description

Multiple Sclerosis (MS) is a chronic neurological disease characterized by local inflammation, gliosis and demyelination in the central nervous system (CNS). It is characterized by demyelinating plaques seen in the brain and medulla spinalis. Many different symptoms can be seen depending on the affected areas in the CNS. One of the common symptoms in these patients is pain. Approximately 50% of patients complain of pain at some point in their lives, and in 20% of them, pain is one of the initial symptoms. Pain may originate from the musculoskeletal system; It may also develop due to inflammation and upper motor neuron damage and may have a neuropathic character. As a result, pain in MS negatively affects patients' physical, emotional functions and quality of life.

Current treatments for pain in MS patients include the use of non-pharmacological interventions such as electrotherapy and exercise, as well as pharmacological treatments. Neurodynamic mobilization exercises are an intervention that aims to restore homeostasis in and around the nervous system by activating the nervous system itself or the structures surrounding the nervous system. Neurodynamic mobilization facilitates movement between neural structures and their environment through manual techniques and exercise. Human and animal studies reveal that neurodynamic mobilization reduces intraneural edema, improves intraneural fluid distribution, reduces thermal and mechanical hyperalgesia, and reverses increased immune responses following a nerve injury.

As a result of this study, it is thought that the determination of effective treatment methods for pain, which is a common symptom of MS patients, will increase the patient's muscle strength and dexterity.

The aim of the study is to examine the effects of neurodynamic mobilization exercises on pain, muscle strength and dexterity in Multiple Sclerosis patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Neurodynamic Mobilization Exercises on Pain, Muscle Strength and Manual Dexterity in Multiple Sclerosis Patients
Actual Study Start Date :
Sep 15, 2023
Anticipated Primary Completion Date :
Jun 15, 2024
Anticipated Study Completion Date :
Jul 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Control Group

Upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks.

Other: strengthening exercises
upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks

Experimental: Study Group

Upper extremity neurodynamic mobilization exercises and upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks.

Other: neurodynamic mobilization exercise
Upper extremity neurodynamic mobilization exercises and upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks.

Other: strengthening exercises
upper extremity strengthening exercises will be applied 10 repetitions a day, 3 days a week for 6 weeks

Outcome Measures

Primary Outcome Measures

  1. Visual Analog Scale [Baseline and after 6 weeks]

    It is a scale used to determine the severity of pain and to clinically monitor pain.

  2. Leeds Assessment of Neuropathic Symptoms and Signs Scale [Baseline and after 6 weeks]

    It is a multidimensional scale based on the analysis of short-term survey data that can be applied to the patient at the bedside, especially used to differentiate neuropathic and nociceptive pain.

Secondary Outcome Measures

  1. Muscle strength [Baseline and after 6 weeks]

    Upper extremity muscles will be evaluated using a digital dynamometer (Knect).

  2. Manual Ability Measure-36 [Baseline and after 6 weeks]

    In this survey, in order to evaluate manual dexterity, it is questioned how difficult it is to perform 36 activities determined to represent daily living activities without the use of assistive devices.

  3. Nine hole peg test [Baseline and after 6 weeks]

    It is a validated test in MS where manual dexterity is measured in seconds based on performance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Being diagnosed with MS according to McDonald 2010 diagnostic criteria

  2. Being between the ages of 18-65

  3. Volunteering to participate in the study

Exclusion Criteria:
  1. Being under 18 years of age and over 65 years of age

  2. Having a history of trauma within the last year

  3. Having alcohol and substance addiction

  4. Having diabetes mellitus

  5. Having another known neurological disease

  6. Being pregnant

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kahramanmaras Sutcu Imam University Kahramanmaraş Turkey

Sponsors and Collaborators

  • Kahramanmaras Sutcu Imam University

Investigators

  • Principal Investigator: Zekiye İpek Katırcı Kırmacı, Kahramanmaras Sütçü İmam University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Zekiye İpek KATIRCI KIRMACI, Asst. Prof, Kahramanmaras Sutcu Imam University
ClinicalTrials.gov Identifier:
NCT06153264
Other Study ID Numbers:
  • ipek.kirmaci
First Posted:
Dec 1, 2023
Last Update Posted:
Dec 1, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zekiye İpek KATIRCI KIRMACI, Asst. Prof, Kahramanmaras Sutcu Imam University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 1, 2023